Role of parenteral nutrition in cancer patients undergoing high-dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation

被引：3
|
作者：
Tartarone, A
Wunder, J
Romano, G
Ardito, R
Iodice, G
Mazzuoli, S
Barone, M
Matera, R
Di Renzo, N
机构：
[1] CROB, Div Med Oncol & Hematol, I-85028 Rionero In Vulture, PZ, Italy
[2] CROB, Unit Dietet & Nutr, I-85028 Rionero In Vulture, PZ, Italy
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Natl Tumor Inst, Naples, Italy
来源：
TUMORI JOURNAL | 2005年 / 91卷 / 03期
关键词：
high-dose chemotherapy; parenteral nutrition;
D O I：
10.1177/030089160509100305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
High-dose chemotherapy followed by autologous bone marrow or peripheral blood progenitor cell transplantation represents a recognized option in the treatment of solid tumors and hematologic diseases. Patients receiving high-dose chemotherapy are traditionally supported with parenteral nutrition with the aim to prevent malnutrition secondary to gastrointestinal toxicity and metabolic alterations induced by the conditioning regimens. Nevertheless, well-defined guidelines for its use in this clinical setting are lacking and there are several areas of controversy.
引用
收藏
页码：237 / 240
页数：4
相关论文
共 50 条
  • [1] Sequential high-dose chemotherapy with autologous peripheral blood progenitor cell transplantation for breast cancer patients.
    Corsini, C
    Agazzi, A
    Paolucci, M
    Tealdo, F
    Peccatori, F
    Goldhirsch, A
    Martinelli, G
    BLOOD, 1997, 90 (10) : 4552 - 4552
  • [2] High-dose chemotherapy followed by autologous peripheral blood progenitor cell rescue in patients with germ-cell tumors
    Nepomucká, J
    Boubliková, L
    Charvát, J
    Simková, V
    Kalanin, J
    Greplová, M
    Bartová, M
    Lukásová, M
    Abrahámová, J
    BONE MARROW TRANSPLANTATION, 1999, 23 : S192 - S192
  • [3] High-dose chemotherapy with four drugs and peripheral blood progenitor cell autologous transplantation in disseminated breast cancer
    Martin, M
    Casado, A
    Llorente, L
    Martin, JAL
    Lescure, AR
    Nieto, Y
    Ayala, F
    Calvo, JP
    Alonso, JL
    Lopez, CP
    Villegas, A
    Diaz-Rubio, E
    MEDICINA CLINICA, 1997, 109 (20): : 775 - 781
  • [4] Symptom profile in cancer patients undergoing high-dose chemotherapy and autologous peripheral stem cell transplantation
    Ozturk, M.
    Komurcu, S.
    Ozet, A.
    Arpaci, F.
    Kuzhan, O.
    Ataergin, S.
    Ozturk, B.
    Ogur, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S420 - S421
  • [5] High-dose therapy followed by autologous peripheral blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Lerma, E
    Deiana, A
    Celesti, L
    Corsetti, MT
    Bruni, R
    Frassoni, F
    Carella, AM
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 701 - 701
  • [6] Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy
    Ferrucci, PF
    Martinoni, A
    Cocorocchio, E
    Civelli, M
    Cinieri, S
    Cardinale, D
    Peccatori, FA
    Lamantia, G
    Agazzi, A
    Corsini, C
    Tealdo, F
    Fiorentini, C
    Cipolla, CM
    Martinelli, G
    BONE MARROW TRANSPLANTATION, 2000, 25 (02) : 173 - 177
  • [7] Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy
    PF Ferrucci
    A Martinoni
    E Cocorocchio
    M Civelli
    S Cinieri
    D Cardinale
    FA Peccatori
    G Lamantia
    A Agazzi
    C Corsini
    F Tealdo
    C Fiorentini
    CM Cipolla
    G Martinelli
    Bone Marrow Transplantation, 2000, 25 : 173 - 177
  • [8] High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancer
    Rodenhuis, S
    Huitema, ADR
    van Dam, FSAM
    de Vries, EGE
    Beijnen, JH
    CANCER JOURNAL, 2000, 6 : S125 - S130
  • [9] High-dose chemotherapy (HDC) with autologous peripheral blood progenitor cell (PBPC) support in patients with metastatic breast cancer
    Constenla, M
    Lorenzo, I
    Carrete, N
    Rey, C
    Campos, B
    Arroyo, FR
    Ozores, R
    Castro, A
    Solla, E
    Villascusa, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S40 - S40
  • [10] Oral mucositis is associated with increased resource utilisation in patients with haematologic malignancies undergoing high-dose therapy followed by autologous peripheral blood progenitor cell transplantation
    Harousseau, JL
    Pico, J
    Boogaerts, M
    Bergmann, OJ
    Martinez, C
    Chen, M
    Lu, J
    BONE MARROW TRANSPLANTATION, 2005, 35 : S191 - S191
12345